|
|
|
|
Takeover of Alpharma Will Give Actavis Rights to Kadian
King Pharmaceuticals acquisition of Alpharma, completed last week, will give the merged company an expanded pain drug portfolio that will include the muscle relaxant Skelaxin, the Flector patch and Embeda.Takeover of Alpharma Will...
|
|
|
King says acquisition of Alpharma is complete, confirms sale of Kadian
to Actavis Article Tools Smaller| Larger Text Story Tools NEW YORK (AP) - King Pharmaceuticals Inc.said Tuesday it completed its $1.6 billion purchase of rival Alpharma, unifying two pain drug makers. King's tender offer for Alpharma...
|
|
|
King Pharma completes $1.6 billion Alpharma buyout
King Pharmaceuticals Inc.said Tuesday it completed its $1.6 billion purchase of rival Alpharma, unifying two pain drug makers. King's tender offer for Alpharma closed Monday morning, with Alpharma stockholders offering 84 percent of...
|
|
|
King Pharma completes $1.6 billion Alpharma buyout
NEW YORK - King Pharmaceuticals Inc.said Tuesday it completed its $1.6 billion purchase of rival Alpharma, unifying two pain drug makers. Related Topic Get stories by e-mail on this topic. KG | RSS ISL | RSS USA | RSS King | RSS...
|
|
|
King Pharma completes $1.6 billion Alpharma buyout
King Pharmaceuticals Inc.said Tuesday it completed its $1.6 billion purchase of rival Alpharma, unifying two pain drug makers. King's tender offer for Alpharma closed Monday morning, with Alpharma stockholders offering 84 percent of...
|
|
|
King Pharma completes $1.6 billion Alpharma buyout
NEW YORK (AP) - King Pharmaceuticals Inc.said Tuesday it completed its $1.6 billion purchase of rival Alpharma, unifying two pain drug makers. King's tender offer for Alpharma closed Monday morning, with Alpharma stockholders offering...
|
|
|
King Pharma completes $1.6 billion Alpharma buyout
King Pharmaceuticals Inc.said Tuesday it completed its $1.6 billion purchase of rival Alpharma, unifying two pain drug makers. King's tender offer for Alpharma (nyse: ALO - news - people ) closed Monday morning, with Alpharma...
|
|
|
King says acquisition of Alpharma is complete, confirms sale of Kadian to Actavis
Article Tools Smaller| Larger Text Story Tools BRISTOL, Tenn.(AP) - King Pharmaceuticals Inc. said Tuesday it completed its $1.6 billion purchase of rival Alpharma, unifying two pain drug makers. King's tender offer for Alpharma...
|
|
|
King Pharma completes $1.6 billion Alpharma buyout
BRISTOL, Tenn.- King Pharmaceuticals Inc. said Tuesday it completed its $1.6 billion purchase of rival Alpharma, unifying two pain drug makers. King's tender offer for Alpharma closed Monday morning, with Alpharma stockholders...
|
|
|
King must sell Kadian assets to buy Alpharma
BRISTOL, Tenn.(AP) - King Pharmaceuticals Inc. said Friday it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King said the Federal Trade Commission has ended a required...
|
|
|
King must sell Kadian assets to buy Alpharma
BRISTOL, Tenn.-King Pharmaceuticals Inc. said Friday it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King said the Federal Trade Commission has ended a required waiting...
|
|
|
FTC rules King Pharmaceuticals will be able to buy Alpharma
Want to use this article?Click here for options! BRISTOL, Tenn! - King Pharmaceuticals Inc. said Friday that it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King...
|
|
|
King Pharma says FTC will approve Alpharma buyout but requires sale of some Kadian assets
BRISTOL, Tenn.(AP) said Friday it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King said the Federal Trade Commission has ended a required waiting period for King's buyout...
|
|
|
King Pharma says FTC will approve Alpharma buyout but requires sale of some Kadian assets
BRISTOL, Tenn.(AP) King Pharmaceuticals Inc. said Friday it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King said the Federal Trade Commission has ended a required...
|
|
|
King must sell Kadian assets to buy Alpharma
King Pharmaceuticals Inc.said Friday it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King said the Federal Trade Commission has ended a required waiting period for King's...
|
|
|
King Pharma says FTC will approve Alpharma buyout but requires sale of some Kadian assets
BRISTOL, Tenn.(AP) said Friday it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King said the Federal Trade Commission has ended a required waiting period for King's buyout...
|
|
|
King Must Sell Kadian Assets to Buy Alpharma
King Pharmaceuticals Inc.said Friday it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King said the Federal Trade Commission has ended a required waiting period for King's...
|
|
|
King Pharma says FTC will approve Alpharma buyout but requires sale of some Kadian assets
King Pharmaceuticals Inc.said Friday it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King said the Federal Trade Commission has ended a required waiting period for King's...
|
|
|
King Pharma says FTC will approve Alpharma buyout but requires sale of some Kadian assets
Article Tools Smaller| Larger Text Story Tools BRISTOL, Tenn.(AP) - King Pharmaceuticals Inc. said Friday it will be allowed to buy Alpharma Inc. provided it sells some assets related to Alpharma's painkiller Kadian. King said the...
|
|
|
King Pharma to acquire Alpharma for about $1.6 billion
BOSTON (Reuters) - King Pharmaceuticals Inc <KG.N> said on Monday it has agreed to acquire Alpharma Inc <ALO.N> for about $1.6 billion to expand its pain drug business.King's offer of $37 a share has been accepted by Alpharma...
|
|
|
King Pharmaceuticals extends Alpharma buyout offer
King Pharmaceuticals Inc.extended its $37-per-share buyout offer for Alpharma Inc. on Monday and said about 92 percent of the company's outstanding shares have been tendered. The offer is now extended to 10.a.m. It was set to expire...
|
|
|
King Pharmaceuticals extends Alpharma buyout offer
Home / The Associated Press NEW YORK - King Pharmaceuticals Inc.extended its $37-per-share buyout offer for Alpharma Inc. on Monday and has already acquired about 92 percent of the company's outstanding stock. The offer is now...
|
|
|
King Pharmaceuticals extends $37-per-share Alpharma buyout
NEW YORK (AP) - King Pharmaceuticals Inc.extended its $37-per-share buyout offer for Alpharma Inc. on Monday and said about 92 percent of the company's outstanding shares have been tendered. The offer is now extended to 10.a.m. It...
|
|
|
King Pharmaceuticals extends Alpharma buyout offer
King Pharmaceuticals Inc.extended its $37-per-share buyout offer for Alpharma Inc. on Monday and said about 92 percent of the company's outstanding shares have been tendered. The offer is now extended to 10.a.m. It was set to expire...
|
|
|
King Pharmaceuticals extends $37 - per - share Alpharma buyout; 92 percent of shares tendered
NEW YORK (AP) - King Pharmaceuticals Inc.extended its $37-per-share buyout offer for Alpharma Inc. on Monday and said about 92 percent of the company's outstanding shares have been tendered. The offer is now extended to 10.a.m. It...
|
